SBIO · ALPS Medical Breakthroughs ETF

$52.90
−1.2% · 1 day, price
Fact sheet
Share ▾
Share on XDownload as PDF
Embed ▾

Free to use with the credit link. It updates every trading night.

Fund card

<iframe src="https://etfiq.com/embed/fund/sbio/" title="ETFIQ SBIO analysis" width="100%" height="250" loading="lazy" style="border:0;max-width:600px"></iframe>
<p>Data: <a href="https://etfiq.com/funds/sbio">ETFIQ SBIO analysis</a></p>

How to embed ETFIQ charts

SBIO tracks an index and returned +13.0% over the past year.

1-year total return
+13.0%to Nov 18, 2026
Expense ratio
0.50%a year
Net flow, 12 months to Aug 31, 2026
+$81.7mmonthly N-PORT basis to Aug 31, 2026
Equity fund · Tracks the S-Network Medical Breakthroughs IndexExpense ratio 0.50%Fund assets $240m net assets, latest filing (Aug 31, 2026)First traded Dec 31, 2014Benchmark Its own holdings, as of Aug 31, 2026; no other fund tracks the S-Network Medical Breakthroughs Index, the index its prospectus namesSEC filings ↗Dividend history

SBIO returned +13.0% over the year to Nov 18, 2026, charges 0.50% a year and holds $240m in net assets on Aug 31, 2026.

Promise check: Not measured

Growth of $10,000

SBIO, 1 year

Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026. No second line: its benchmark is its own holdings, which have no daily price series.

SBIO $11,304 +13.0%Returns from daily closes. Data
Scorecard · vs

SBIO risk and return scorecard

vs its own holdings

Not measured: its benchmark is its own holdings, which has no weekly price series.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Net fund flows · monthly N-PORT basis · as of Aug 31, 2026

Money in and out

12 months to Aug 31, 2026
+$81.7m
N-PORT monthly basis
3 years to Aug 31, 2026
+$50.7m
N-PORT monthly basis
5 years to Aug 31, 2026
+$11.7m
N-PORT monthly basis
Total return

What you earned

SBIO +1.5%: total return over one month to Nov 18, 2026.
$10,000 in SBIO would be $10,150.
SBIO+1.5%
SBIO −25.3%: total return over three months to Nov 18, 2026.
$10,000 in SBIO would be $7,470.
SBIO−25.3%
SBIO +0.1%: total return over six months to Nov 18, 2026.
$10,000 in SBIO would be $10,010.
SBIO+0.1%
SBIO +3.3%: total return year to date, Dec 31, 2025 to Nov 18, 2026.
$10,000 in SBIO would be $10,330.
SBIO+3.3%
SBIO +13.0%: total return over one year to Nov 18, 2026.
$10,000 in SBIO would be $11,304.
SBIO+13.0%
SBIO +114.9%: total return over three years to Nov 18, 2026.
$10,000 in SBIO would be $21,490.
SBIO+114.9%
SBIO +22.1%: total return over five years to Nov 18, 2026.
$10,000 in SBIO would be $12,210.
SBIO+22.1%
SBIO +123.2%: total return over ten years to Nov 18, 2026.
$10,000 in SBIO would be $22,320.
SBIO+123.2%
SBIO +131.5%: total return since launch to Nov 18, 2026.
$10,000 in SBIO would be $23,150.
SBIO+131.5%
Fees over time · hypothetical
Fees paid
$489
Of the amount
4.9%

At SBIO’s 0.5% a year, taken each year from the amount after growth.

S-Network Medical Breakthroughs Index

How concentrated, and what does it cost?

+13.0%
Total return, 1 year
0.50%
Expense ratio
103
Holdings
−25.3%
Below its high
$1.1735
Last payment (paid annually), ex-date Dec 19, 2024
Sector mix
Cost against like funds

7 of 12 committee seats measured SBIO.

0 Supports0 Mixed7 Challenges5 Not enough data
  • Bogle
  • Graham
  • Buffett & Munger
  • Lynch
  • Templeton
  • Dalio
  • Marks
  • Druckenmiller
  • Swensen
  • Wood
  • Livermore
  • Skeptic

Watch the committee read SBIO How the committee works

12 seats on SBIO, as of Nov 18, 2026: 7 Challenges, 5 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyChallenges
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskChallenges
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationNot enough data
In the tradition ofJesse LivermoreLivermore-style Trend FollowingChallenges
Uses ETFIQ’s measuresETFIQ SkepticETFIQ’s own seatNot enough data
Put SBIO to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Risk Officer

Risk check

What to look at before you hold SBIO.

As of Nov 18, 2026, SBIO crossed 0 of 5 ETFIQ risk lines.

OverlapNot publishedNot published
Trading costNot publishedNot published
Premium or discountNot publishedNot published
ConcentrationTop 10 holdings are 31.4% of the fundClear
ClosureNo closure flagClear

Lines and sources: Method. Check several funds at once on My Portfolio.

More on SBIO

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price, 1 year

$52.90−1.2%1 day, priceClose, Nov 18, 2026

Price only. No distribution was paid over these days, so total return is the same. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Nov 18, 2026. Updated every trading night. Report a data error

Points (pts) are percentage points.

SBIO returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Oct 19 – Nov 18, 2026+1.5%−4.7%
3M Aug 19 – Nov 18, 2026−25.3%−4.8%
6M May 20 – Nov 18, 2026+0.1%−1.0%
YTD Dec 31, 2025 – Nov 18, 2026+3.3%+7.9%
1Y Nov 18, 2025 – Nov 18, 2026+13.0%+11.8%
3Y Nov 17, 2023 – Nov 18, 2026+114.9%+68.0%
5Y Nov 19, 2021 – Nov 18, 2026+22.1%+66.5%
10Y Nov 18, 2016 – Nov 18, 2026+123.2%+291.6%
Since launch Dec 31, 2014 – Nov 18, 2026+131.5%+331.5%
Since launch, annualised Dec 31, 2014 – Nov 18, 2026+7.3%–

Total returns, distributions reinvested.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Monthly data · as of Aug 31, 2026

SBIO: in the month to Aug 31, 2026, net $29.1m came in, by its SEC filing.

12 months
+$81.7m
100.8% of $81.0m on Aug 31, 2025
Sep 1, 2025 to Aug 31, 2026
monthly, from SEC filings
3 years
+$50.7m
50.1% of $101m on Aug 31, 2023
Sep 1, 2023 to Aug 31, 2026
monthly, from SEC filings
5 years
+$11.7m
5.5% of $213m on Aug 31, 2021
Sep 1, 2021 to Aug 31, 2026
monthly, from SEC filings
Since Sep 2019
+$2.2m
Sep 1, 2019 to Aug 31, 2026
monthly, from SEC filings

Computed by ETFIQ from the monthly sales and redemptions SBIO files with the SEC on Form N-PORT.

How this is computed

ETFIQ reads no daily data for this fund, so its flows are monthly, and the latest month filed is Aug 2026. Every day and month ETFIQ holds for SBIO, back to Sep 2019, is in its flows file. Flows across every fund · How these flows are computed · Compare SBIO with other funds in the flows tool

Month by month, money in and money outSep 2023 to Aug 2026

SBIO, money in and money out each month from Sep 2023 to Aug 2026: two bars a month, money in above the line and money out below. Every bar is from SBIO’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 12 and went out in 22.

Every bar is from SBIO’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 12 and went out in 22.

MonthInOutNet
Aug 2026 SEC Form N-PORT+$29.1m$0+$29.1m
Jul 2026 SEC Form N-PORT+$15.0m$0+$15.0m
Jun 2026 SEC Form N-PORT+$4.5m−$5.2m−$765k
May 2026 SEC Form N-PORT+$4.1m$0+$4.1m
Apr 2026 SEC Form N-PORT+$22.2m−$1.4m+$20.7m
Mar 2026 SEC Form N-PORT$0−$7.4m−$7.4m
Feb 2026 SEC Form N-PORT+$3.8m−$5.1m−$1.3m
Jan 2026 SEC Form N-PORT+$11.8m−$1.2m+$10.5m
Dec 2025 SEC Form N-PORT+$20.2m$0+$20.2m
Nov 2025 SEC Form N-PORT+$10.6m$0+$10.6m
Oct 2025 SEC Form N-PORT+$4.2m−$25.3m−$21.1m
Sep 2025 SEC Form N-PORT+$2.7m−$955k+$1.8m
Aug 2025 SEC Form N-PORT$0−$876k−$876k
Jul 2025 SEC Form N-PORT$0−$9.2m−$9.2m
Jun 2025 SEC Form N-PORT$0−$4.7m−$4.7m
May 2025 SEC Form N-PORT$0−$1.4m−$1.4m
Apr 2025 SEC Form N-PORT+$714k−$1.4m−$707k
Mar 2025 SEC Form N-PORT$0−$3.8m−$3.8m
Feb 2025 SEC Form N-PORT$0−$3.3m−$3.3m
Jan 2025 SEC Form N-PORT$0−$829k−$829k
Dec 2024 SEC Form N-PORT$0−$1.8m−$1.8m
Nov 2024 SEC Form N-PORT+$2.9m$0+$2.9m
Oct 2024 SEC Form N-PORT+$2.9m−$942k+$2.0m
Sep 2024 SEC Form N-PORT$0$0$0
Aug 2024 SEC Form N-PORT$0−$1.8m−$1.8m
Jul 2024 SEC Form N-PORT$0$0$0
Jun 2024 SEC Form N-PORT+$833k−$829k+$5k
May 2024 SEC Form N-PORT+$4.2m−$7.6m−$3.4m
Apr 2024 SEC Form N-PORT+$1.6m−$2.5m−$930k
Mar 2024 SEC Form N-PORT+$872k−$890k−$18k
Feb 2024 SEC Form N-PORT+$6.3m$0+$6.3m
Jan 2024 SEC Form N-PORT$0−$800k−$800k
Dec 2023 SEC Form N-PORT$0−$3.0m−$3.0m
Nov 2023 SEC Form N-PORT$0−$1.8m−$1.8m
Oct 2023 SEC Form N-PORT$0−$3.1m−$3.1m
Sep 2023 SEC Form N-PORT$0−$740k−$740k

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s SEC N-PORT filings. Data as of Aug 31, 2026. Updated when the fund files its next report.

SBIO key stats

52-week high, daily closes to Nov 18, 2026 (ETFIQ)$70.79 on Aug 19, 2026
52-week low, daily closes to Nov 18, 2026 (ETFIQ)$46.08 on Nov 20, 2025
Close on Nov 18, 2026, within that range (ETFIQ)$52.90, 28% of the way from the low to the high
Holdings103
Top ten weight31.4%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Nov 18, 2026
Trading · SBIOas of Nov 18, 2026
·
Not scored1 of 6 measured · Nov 18, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
How to tradeSpread not read.
Full trading page: components, premium history, dealers →

SBIO for holders outside the US

US tax withheld on dividends, no treaty30%
Treaty rates on dividends (IRS table, read Oct 30, 2026)65 countries, 10% to 30%
SBIO interest-related and short-term gain dividendsnot read by ETFIQ
US estate tax filing threshold, non-resident holders$60,000
Share classDistributing

SBIO is a US fund. Stock of US corporations counts as US property for a non-resident's estate. Facts from the IRS, not tax advice. How withholding and treaties work
Name vs holdings

What its name promises, against what it held, as of Aug 31, 2026.

Health carePromise check:

Holds: 100.0% in health care, of the 90.2% of holdings SIC codes place.

Name: at least 80% of assets in health care, the SEC's Names Rule.

Download all holdings

SBIO top ten by weight, 31.4% of the fund, of its 103 equity positions, from the holdings filed for Aug 31, 2026. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

Source: Holdings filing (SEC Form N-PORT).

About SBIO

What it tracksS-Network Medical Breakthroughs Index
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Region (ETFIQ)United States
Expense ratio (485BPOS XBRL, Mar 30, 2026)0.50%
Price$52.90
First tradedDec 31, 2014
Net assets (SEC filing, whole fund, as filed for Aug 31, 2026)$240mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of Aug 31, 2026; no other fund tracks the S-Network Medical Breakthroughs Index, the index its prospectus names
SBIO, Aug 31, 2026 to Oct 30, 2026−17.88%
Its book of Aug 31, 2026, the same days (ETFIQ, measured on 91% of the book by weight)−17.63%
Against its own holdings (ETFIQ)−0.25 pts
Stated benchmarkS-Network Medical Breakthroughs Index (from its prospectus). SBIO is the only ETF ETFIQ covers that tracks it.
Below its high (ETFIQ)−25.3%
Holdings103
Top ten weight31.4%
Cash, not in the top ten0.0%
Holdings as of (SEC N-PORT)Aug 31, 2026
Already in the S&P 500, by weight (ETFIQ)0.0%
Active share vs the S&P 500 (ETFIQ)100.0%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
ISINUS00162Q5936
CUSIP00162Q593
Promise checkNot measured. No other ETF tracks the index it names, so its tracking cannot be measured.

Questions people ask about SBIO

How has SBIO performed?
Over the year to Nov 18, 2026, SBIO returned +13.0% with distributions reinvested. Over three years the number is +114.9%.
What does SBIO cost?
The prospectus expense ratio is 0.50% a year.
What does SBIO hold?
103 positions as filed for Aug 31, 2026, with the top ten at 31.4% of the fund. 0% of its weight is in stocks the S&P 500 also holds.
How far is SBIO below its high?
25.3% below its high of Aug 19, 2026, measured on the reinvested series to Nov 18, 2026.
Sources and dates
Prices, SBIO and S&P 500 (SPY)Tiingo end-of-day · Nov 18, 2026
Net assets, $240mSEC filing, whole fund · Aug 31, 2026
ISIN and CUSIPSEC fails-to-deliver files, OpenFIGI

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, SBIO, stock fund, data as of Nov 18, 2026. https://etfiq.com/funds/sbio

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

SBIO: SBIO over 1 year: total return +13.0%. Data to Nov 18, 2026.
<figure style="margin:0;max-width:640px">
<iframe src="https://etfiq.com/embed/core/sbio/" title="SBIO: SBIO over 1 year: total return +13.0%. Data to Nov 18, 2026." width="640" height="370" loading="lazy" style="border:0;max-width:100%;width:100%"></iframe>
<figcaption style="font:13px/1.5 sans-serif">SBIO: SBIO over 1 year: total return +13.0%. Data to Nov 18, 2026. Data: <a href="https://etfiq.com/funds/sbio">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Nov 18, 2026. More on the tabs above.